Ectopic Pregnancy Clinical Trial
Official title:
Evaluation of Reproductive Outcomes After Expectant or Surgical Management of a Previous Episode of Tubal Ectopic Pregnancy
NCT number | NCT05479786 |
Other study ID # | ECTO-1 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2012 |
Est. completion date | December 31, 2020 |
Verified date | July 2022 |
Source | University of Palermo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Although ectopic pregnancy was considered a leading cause of first-trimester maternal mortalities, current technological improvements allowed early diagnosis and opened a door for applying less invasive approaches. A tubal pregnancy could be managed either expectantly, medically, or surgically. The expectant management of ectopic pregnancy relies on the fact that a considerable proportion of ectopic gestations terminate by spontaneous tubal abortion. This approach is usually kept for stable cases with a small gestational sac and low beta-human chorionic gonadotropin (beta-HCG) serum levels. For hemodynamically unstable patients, higher levels of beta-HCG, and larger gestational sacs, surgery is often considered as the treatment of choice (16). Considering this background, the study aims to analyze the subsequent natural reproductive outcomes of patients that had a previous tubal ectopic pregnancy and were managed either expectantly or surgically. Moreover, it amis to determine the factors that could influence the fertility potential of these patients in each treatment group.
Status | Completed |
Enrollment | 312 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Women with one episode of tubal ectopic pregnancy, treated by expectant management, salpingectomy, or salpingostomy; - For patients treated surgically, only patients with at least one patent Fallopian tube confirmed via postoperative hysterosalpingography were included in the analysis. Exclusion Criteria: - Pregnancies of unknown location - Other types of ectopic pregnancy - Pelvic inflammatory disease - Pelvic adhesions - Intrauterine pathologies - Pregnancies obtained after assisted-reproductive technologies (ART) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Palermo | Damascus University, University of Debrecen |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical pregnancy rate | Presence of a gestational sac under ultrasonography | Within one year after the previous episode of tubal ectopic pregnancy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02995356 -
Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy
|
||
Completed |
NCT01876004 -
Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy
|
Phase 4 | |
Not yet recruiting |
NCT05039853 -
Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task
|
N/A | |
Completed |
NCT00194207 -
Risk Factors of Ectopic Pregnancy
|
N/A | |
Completed |
NCT00827970 -
Randomized Population-Based Study on Chlamydia Trachomatis Screening
|
N/A | |
Recruiting |
NCT05374720 -
Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy
|
N/A | |
Completed |
NCT03894735 -
Vitamin D in Ectopic Pregnancies
|
||
Recruiting |
NCT01860690 -
BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success
|
Phase 4 | |
Recruiting |
NCT04176549 -
Assessment of Biomarkers in Ectopic Pregnancy
|
||
Not yet recruiting |
NCT05890066 -
Single-port Versus Multi-port Laparoscopic Surgery for Ectopic Pregnancy
|
N/A | |
Completed |
NCT01855568 -
Methotrexate Treatment for Ectopic Pregnancy
|
Phase 3 | |
Not yet recruiting |
NCT04308343 -
The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
|
N/A | |
Recruiting |
NCT06354439 -
Use of Letrozole for Ectopic Pregnancy
|
Phase 4 | |
Not yet recruiting |
NCT06300333 -
Treatment of Ectopic Pregnancy by Low Dose of Methotrexate
|
||
Completed |
NCT00194272 -
Two-Dose Methotrexate for Ectopic Pregnancy
|
Phase 3 | |
Enrolling by invitation |
NCT03579550 -
Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus
|
N/A | |
Completed |
NCT05446012 -
Relationship Between Ectopic Pregnancy and Thyroid Disorders
|
||
Completed |
NCT00194168 -
Ectopic Pregnancy Biomarkers
|
N/A | |
Completed |
NCT02152696 -
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
|
Phase 3 | |
Not yet recruiting |
NCT04975984 -
Expectant Management of Ectopic Pregnancy
|